Investing time in modeling PK/PD data can have great benefits! One major benefit is the ability to simulate potential variations on dosing regimens as well as predict drug plasma concentrations after multiple dosing to evaluate the safety and efficacy of a drug. In this webinar, learn how to use Phoenix WinNonlin to simulate drug concentration-time data at steady-state from single dose data.